vildagliptin (LAF237)

vildagliptin · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for vildagliptin (LAF237), covering 2020-12-19 to 2020-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Drug Interaction of Vildagliptin (LAF237) With Voglibose in Japanese Patients With Type 2 Diabetes [Phase 4]